Celsion Corporation (CLSN)

[sdtrond]

Regarding the other two posts you made after the one I'm replying to, why on earth do you keep talking about general HCC stats? I am talking about the population for HEAT. I am ignoring those because they say nothing about our central disagreement.

Again, from the 2Q12 cc, "In our target population, median time to progression is 12 months..."

Your point:
"(1) TPS does not equal PFS."

I'm assuming you mean TTP - time to progression?
So you are correct, they are not equal. My point is that TTP will be lower than PFS. Do you disagree on this?

"(2) Since the survival stats of 30 months matches their previous stats for general HCC, it's not what you think it is. Target population is HCC. It's a target POPULATION."

I concede the possibility. But I maintain since he talks about the trial AND Thermodox right before and after that commment, when he says population he means the trial population.
"OUR population" definitely connotes that he is talking about what TDox would affect, not a general HCC population.

We disagree on RFA-only PFS... but we both think it will succeed. That's good enough for me.